ToughtoTreat

Cara Murez FRIDAY, June 2, 2023 (HealthDay News) -- Not a lot is known about how physicians should handle cases in which a pregnant woman is diagnosed with relapsed/refractory lymphoma.A new…

Cara Murez THURSDAY, May 25, 2023 (HealthDay News) -- Ketamine may be an alternative to shock treatment for people with treatment-resistant major depression, a new study suggests.Currently,…

Cara Murez MONDAY, Dec. 19, 2022 (HealthDay News) -- Patients with a high-risk bladder cancer now have a new option to treat it.The U.S. Food and Drug Administration on Friday approved a gene therapy…

Dennis Thompson TUESDAY, Nov. 1, 2022 (HealthDay News) -- Doctors could soon have access to a new weapon in the ongoing battle against antibiotic-resistant bacteria.An experimental combination…

By LAURAN NEERGAARD - AP Medical Writer In a novel experiment, a woman with advanced pancreatic cancer saw her tumors dramatically shrink after researchers in Oregon turbocharged her own immune cells,…

PHOENIX -- Patients who received add-on dupilumab (Dupixent) treatment for chronic spontaneous urticaria (CSU) had reduced symptoms and experienced less itchiness, a phase III trial…

Lemzoparlimab, a novel CD47 antibody, in combination with rituximab was safe and well tolerated in heavily treated patients with relapsed or refractory…

Investigational bulevirtide (Hepcludex) was effective and well tolerated in patients with chronic hepatitis delta virus (HDV), a researcher reported. In an interim…

Treatment with cabozantinib (Cabometyx) significantly improved progression-free survival (PFS) in patients with radioactive iodine (RAI)-refractory differentiated thyroid cancer, an…